|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/96 | |
| C12P 21/02 |
| (11) | Number of the document | 2435459 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10781143.2 |
| Date of filing the European patent application | 2010-05-26 | |
| (97) | Date of publication of the European application | 2012-04-04 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/036225 |
| Date | 2010-05-26 |
| (87) | Number | WO 2010/138608 |
| Date | 2010-12-02 |
| (30) | Number | Date | Country code |
| 181255 P | 2009-05-26 | US |
| (72) |
DO, Hung, V., US
|
| (73) |
Amicus Therapeutics, Inc.,
1 Cedar Brook Drive, Cranbury, NJ 08512,
US
|
| (54) | UTILIZATION OF PHARMACOLOGICAL CHAPERONES TO IMPROVE MANUFACTURING AND PURIFICATION OF ACID BETA-GLUCOSIDASE |
| UTILIZATION OF PHARMACOLOGICAL CHAPERONES TO IMPROVE MANUFACTURING AND PURIFICATION OF ACID BETA-GLUCOSIDASE |